These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 1270877

  • 1. Correction of protein binding defect in uremic sera by charcoal treatment.
    Craig WA, Evenson MA, Sarver KP, Wagnild JP.
    J Lab Clin Med; 1976 Apr; 87(4):637-47. PubMed ID: 1270877
    [Abstract] [Full Text] [Related]

  • 2. Reduced in vitro displacement of valproic acid from protein binding by salicylate in uremic sera compared with normal sera. Role of uremic compounds.
    Dasgupta A, Jacques M.
    Am J Clin Pathol; 1994 Mar; 101(3):349-53. PubMed ID: 8135194
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Endogenous accumulation products and serum protein binding in uremia.
    McNamara PJ, Lalka D, Gibaldi M.
    J Lab Clin Med; 1981 Nov; 98(5):730-40. PubMed ID: 7299243
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diminished protein binding capacity of uremic sera for valproate following hemodialysis: role of free fatty acids and uremic compounds.
    Dasgupta A, Jacques M, Malhotra D.
    Am J Nephrol; 1996 Nov; 16(4):327-33. PubMed ID: 8739287
    [Abstract] [Full Text] [Related]

  • 7. Changes in protein binding during disease.
    Craig WA, Suh B.
    Scand J Infect Dis Suppl; 1978 Nov; (14):239-44. PubMed ID: 279978
    [Abstract] [Full Text] [Related]

  • 8. Phenytoin-oxacillin interactions in normal and uremic sera.
    Dasgupta A, Sperelakis A, Mason A, Dean R.
    Pharmacotherapy; 1997 Nov; 17(2):375-8. PubMed ID: 9085332
    [Abstract] [Full Text] [Related]

  • 9. Increased free phenytoin concentrations in predialysis serum compared to postdialysis serum in patients with uremia treated with hemodialysis. Role of uremic compounds.
    Dasgupta A, Abu-Alfa A.
    Am J Clin Pathol; 1992 Jul; 98(1):19-25. PubMed ID: 1615921
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.
    Tsubakihara Y, Takabatake Y, Oka K, Shoji T, Togawa M, Okada N, Takahito I, Imai E.
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S38-41. PubMed ID: 12612950
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. New approaches to the removal of protein-bound toxins from blood plasma of uremic patients.
    Sarnatskaya VV, Yushko LA, Sakhno LA, Nikolaev VG, Nikolaev AV, Grinenko DV, Mikhalovsky SV.
    Artif Cells Blood Substit Immobil Biotechnol; 2007 Mar; 35(3):287-308. PubMed ID: 17573628
    [Abstract] [Full Text] [Related]

  • 14. Carbamazepine-salicylate interaction in normal and uremic sera: reduced interaction in uremic sera.
    Dasgupta A, Thompson WC.
    Ther Drug Monit; 1995 Apr; 17(2):199-202. PubMed ID: 7624911
    [Abstract] [Full Text] [Related]

  • 15. Impaired protein binding of Chinese medicine DanShen in uremic sera and sera with hyperbilirubinemia: rapid assessment of total and free DanShen concentrations using the fluorescence polarization immunoassay for digoxin.
    Wahed A, Pollard J, Wells A, Dasgupta A.
    J Clin Lab Anal; 2003 Apr; 17(5):179-83. PubMed ID: 12938147
    [Abstract] [Full Text] [Related]

  • 16. Unexpected suppression of free phenytoin concentration by salicylate in uremic sera due to the presence of inhibitors: MALDI mass spectrometric determination of molecular weight range of inhibitors.
    Biddle DA, Wells A, Dasgupta A.
    Life Sci; 2000 Apr; 66(2):143-51. PubMed ID: 10666010
    [Abstract] [Full Text] [Related]

  • 17. Elevated free fatty acid concentrations in lipemic sera reduce protein binding of valproic acid significantly more than phenytoin.
    Dasgupta A, Crossey MJ.
    Am J Med Sci; 1997 Feb; 313(2):75-9. PubMed ID: 9030671
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Uremic sera contain inhibitors that block digitoxin-valproic acid interaction.
    Dasgupta A, Paul A, Wells A.
    Am J Med Sci; 2001 Oct; 322(4):204-8. PubMed ID: 11678517
    [Abstract] [Full Text] [Related]

  • 20. The alteration of plasma proteins in uremia as reflected in their ability to bind digitoxin and diphenylhydantoin.
    Shoeman DW, Azarnoff DL.
    Pharmacology; 1972 Oct; 7(3):169-77. PubMed ID: 5054587
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.